Chemed (CHE)
(Delayed Data from NYSE)
$641.93 USD
-2.33 (-0.36%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $641.92 -0.01 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth D Momentum C VGM
Price, Consensus and EPS Surprise
CHE 641.93 -2.33(-0.36%)
Will CHE be a Portfolio Killer in March?
Zacks Investment Research is releasing its prediction for CHE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CHE
Chemed (CHE) Up 2.5% Since Last Earnings Report: Can It Continue?
Chemed (CHE) Reaches a New 52-Week High: What's Driving It?
CHE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Chemed's (CHE) VITAS Segment Inks New Deal With Covenant Care
Centene (CNC), Pearl Health Unite to Enhance Value-Based Care
Here's Why You Should Add Cigna (CI) Stock to Your Portfolio
Other News for CHE
Chemed Corp VP and Chief Legal Officer Brian Judkins Sells 11,158 Shares
Analysts Offer Insights on Healthcare Companies: Chemed (CHE), Ionis Pharmaceuticals (IONS) and Arcellx Inc (ACLX)
VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama
VITAS Healthcare to acquire hospice assets of Covenant Care in Florida and Alabama
Dividend Champion, Contender, And Challenger Highlights: Week Of March 10